GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » PB Ratio

Captor Therapeutics (WAR:CTX) PB Ratio : 5.13 (As of May. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Captor Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-11), Captor Therapeutics's share price is zł76.40. Captor Therapeutics's Book Value per Share for the quarter that ended in Dec. 2023 was zł14.90. Hence, Captor Therapeutics's PB Ratio of today is 5.13.

The historical rank and industry rank for Captor Therapeutics's PB Ratio or its related term are showing as below:

WAR:CTX' s PB Ratio Range Over the Past 10 Years
Min: 4.17   Med: 6.12   Max: 11.52
Current: 5.42

During the past 7 years, Captor Therapeutics's highest PB Ratio was 11.52. The lowest was 4.17. And the median was 6.12.

WAR:CTX's PB Ratio is ranked worse than
78.49% of 1311 companies
in the Biotechnology industry
Industry Median: 2.5 vs WAR:CTX: 5.42

During the past 12 months, Captor Therapeutics's average Book Value Per Share Growth Rate was -35.50% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Captor Therapeutics was 205.60% per year. The lowest was 160.10% per year. And the median was 182.85% per year.

Back to Basics: PB Ratio


Captor Therapeutics PB Ratio Historical Data

The historical data trend for Captor Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Therapeutics PB Ratio Chart

Captor Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - - 5.98 6.92 6.64

Captor Therapeutics Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.92 7.85 11.52 11.44 6.64

Competitive Comparison of Captor Therapeutics's PB Ratio

For the Biotechnology subindustry, Captor Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Captor Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Captor Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Captor Therapeutics's PB Ratio falls into.



Captor Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Captor Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=76.40/14.9
=5.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Captor Therapeutics  (WAR:CTX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Captor Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Captor Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Captor Therapeutics (WAR:CTX) Business Description

Traded in Other Exchanges
Address
ul. Dunska 11, Wroclaw, POL, 54-427
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.

Captor Therapeutics (WAR:CTX) Headlines

No Headlines